Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

NCT02353468 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Principle investigator left the institution

Conditions

Refractory Plasma Cell Myeloma

Interventions

DRUG: Bortezomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

University of Colorado, Denver